Welcome to IFMAD Survey Questionnaire about digital therapeutics

Otsuka Pharmaceutical Europe Ltd. is conducting a survey to explore healthcare professionals’ use of digital therapeutics in managing depressive disorders. Otsuka Pharmaceutical is a global healthcare company with the corporate philosophy: ‘Otsuka-people creating new products for better health worldwide.’ Our 34,400 employees channel their passion and commitment into aiming to improve the health of our patients, with a focus in Europe on therapies in mental health, nephrology and immunology, haemato-oncology, infectious diseases and digital therapeutics. We truly value your expertise and would greatly appreciate your input on this important initiative.

Otsuka Pharmaceutical Europe Ltd is a sponsor of IFMAD Conference 2025.

This survey questionnaire has been developed and funded by Otsuka Pharmaceutical Europe Ltd. It is intended for healthcare professionals only.

Lena Corporation S.A.M. – Lena Group

+377 97 97 35 55
info@ifmad.org

Job code: OPE-DM-2500023 (v1.0). Date of preparation: April 2025

Missed the Event? Catch Up Anytime!

If you were unable to attend, or would like to revisit the sessions, presentations are available now.

How to access?

  • Forum attendee: Log in to your profile and access the presentations through your dashboard 

  • If you were unable to attend register here to access presentations